Gyre Therapeutics (GYRE) Current Assets (2010 - 2026)
Gyre Therapeutics (GYRE) reported Current Assets of $91.7 million for Q1 2026, up 34.02% year-over-year from $68.4 million in Q1 2025, and down 10.39% on a QoQ basis from $102.4 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Current Assets data on file, last reported at $91.7 million in Q1 2026.
- Quarterly Current Assets rose 34.02% year-over-year to $91.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.7 million (up 34.02% YoY) and the FY2025 annual result came in at $102.4 million, up 58.01% from the prior year.
- Current Assets declined to $91.7 million in Q1 2026 per GYRE's latest filing, from $102.4 million in the prior quarter.
- Across five years, Current Assets topped out at $102.4 million in Q4 2025 and bottomed at $5.1 million in Q3 2023.
- The 5-year median for Current Assets is $57.2 million (2023), against an average of $57.1 million.
- The widest annual swing landed in 2023, when Current Assets tumbled 90.63%; it then jumped 967.99% in 2024.
- Tracing GYRE's Current Assets over 5 years: stood at $49.7 million in 2022, then rose by 15.24% to $57.2 million in 2023, then rose by 13.22% to $64.8 million in 2024, then soared by 58.01% to $102.4 million in 2025, then retreated by 10.39% to $91.7 million in 2026.
- Per Business Quant, the three latest GYRE Current Assets figures stand at $91.7 million (Q1 2026), $102.4 million (Q4 2025), and $98.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 91.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.73 Mn |
| Dec 31, 2025 | 102.37 Mn |
| Sep 30, 2025 | 98.58 Mn |
| Jun 30, 2025 | 91.29 Mn |
| Mar 31, 2025 | 68.45 Mn |
| Dec 31, 2024 | 64.79 Mn |
| Sep 30, 2024 | 54.81 Mn |
| Jun 30, 2024 | 53.52 Mn |
| Mar 31, 2024 | 62.72 Mn |
| Dec 31, 2023 | 57.22 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 14.01 Mn |
| Dec 31, 2022 | 49.65 Mn |
| Sep 30, 2022 | 30.25 Mn |
| Jun 30, 2022 | 81.31 Mn |
| Mar 31, 2022 | 36.70 Mn |
| Dec 31, 2021 | 51.48 Mn |
| Sep 30, 2021 | 73.96 Mn |
| Jun 30, 2021 | 96.83 Mn |
| Mar 31, 2021 | 116.52 Mn |
| Dec 31, 2020 | 89.51 Mn |
| Sep 30, 2020 | 107.97 Mn |
| Jun 30, 2020 | 121.35 Mn |
| Mar 31, 2020 | 108.28 Mn |
| Dec 31, 2019 | 96.07 Mn |
| Sep 30, 2019 | 89.14 Mn |
| Jun 30, 2019 | 98.06 Mn |
| Mar 31, 2019 | 109.00 Mn |
| Dec 31, 2018 | 123.99 Mn |
| Sep 30, 2018 | 132.81 Mn |
| Jun 30, 2018 | 138.98 Mn |
| Mar 31, 2018 | 145.43 Mn |
| Dec 31, 2017 | 39.11 Mn |
| Sep 30, 2017 | 34.08 Mn |
| Jun 30, 2017 | 39.27 Mn |
| Mar 31, 2017 | 28.54 Mn |
| Dec 31, 2016 | 37.52 Mn |
| Sep 30, 2016 | 50.78 Mn |
| Jun 30, 2016 | 56.29 Mn |
| Mar 31, 2016 | 60.74 Mn |
| Dec 31, 2015 | 68.70 Mn |
| Sep 30, 2015 | 72.85 Mn |
| Jun 30, 2015 | 100.19 Mn |
| Mar 31, 2015 | 105.24 Mn |
| Dec 31, 2014 | 2.07 Mn |
| Sep 30, 2014 | 98.99 Mn |
| Jun 30, 2014 | 98.75 Mn |
| Mar 31, 2014 | 98.48 Mn |
| Dec 31, 2013 | 93.61 Mn |
| Sep 30, 2013 | 98.59 Mn |
| Jun 30, 2013 | 102.52 Mn |
| Mar 31, 2013 | 111.63 Mn |
| Dec 31, 2012 | 127.74 Mn |
| Sep 30, 2012 | 148.10 Mn |
| Jun 30, 2012 | 159.17 Mn |
| Mar 31, 2012 | 179.34 Mn |
| Dec 31, 2011 | 198.22 Mn |
| Sep 30, 2011 | 216.81 Mn |
| Jun 30, 2011 | 237.03 Mn |
| Dec 31, 2010 | 218.08 Mn |